In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking

被引：0
|
作者：
Liang-qin Gao
Jing Xu
Shao-dong Chen
机构：
[1] Xiamen University,Department of Traditional Chinese Medicine, Xiamen University Hospital
[2] Xiamen University,College of Ocean and Earth Sciences
[3] Xiamen University,Department of Traditional Chinese Medicine, School of Medicine
来源：
Chinese Journal of Integrative Medicine | 2020年 / 26卷
关键词：
molecular docking; COVID-19; SARS-CoV-2 3CL hydrolytic enzyme; angiotensin converting enzyme II; Chinese medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：527 / 532
页数：5
相关论文
共 50 条
  • [21] In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses
    Yalcin, Serap
    Yalcinkaya, Seda
    Ercan, Fahriye
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1240
  • [22] Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19
    Abe, Kodai
    Kabe, Yasuaki
    Uchiyama, Susumu
    Iwasaki, Yuka W.
    Ishizu, Hirotsugu
    Uwamino, Yoshifumi
    Takenouchi, Toshiki
    Uno, Shunsuke
    Ishii, Makoto
    Maruno, Takahiro
    Noda, Masanori
    Murata, Mitsuru
    Hasegawa, Naoki
    Saya, Hideyuki
    Kitagawa, Yuko
    Fukunaga, Koichi
    Amagai, Masayuki
    Siomi, Haruhiko
    Suematsu, Makoto
    Kosaki, Kenjiro
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19
    Ansari, Mohammad Azam
    Jamal, Qazi Mohammad Sajid
    Rehman, Suriya
    Almatroudi, Ahmad
    Alzohairy, Mohammad A.
    Alomary, Mohammad N.
    Tripathi, Takshashila
    Alharbi, Ali H.
    Adil, Syed Farooq
    Khan, Mujeeb
    Malik, M. Shaheer
    ARABIAN JOURNAL OF CHEMISTRY, 2020, 13 (11) : 8069 - 8079
  • [24] Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors
    Shirvaliloo, Milad
    FUTURE CARDIOLOGY, 2021, 17 (05) : 765 - 768
  • [25] Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study
    Gorai, Sudip
    Junghare, Vivek
    Kundu, Kshama
    Gharui, Sowmomita
    Kumar, Mukesh
    Patro, Birija Sankar
    Nayak, Sandip K.
    Hazra, Saugata
    Mula, Soumyaditya
    CHEMMEDCHEM, 2022, 17 (08)
  • [26] Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19
    Kodai Abe
    Yasuaki Kabe
    Susumu Uchiyama
    Yuka W. Iwasaki
    Hirotsugu Ishizu
    Yoshifumi Uwamino
    Toshiki Takenouchi
    Shunsuke Uno
    Makoto Ishii
    Takahiro Maruno
    Masanori Noda
    Mitsuru Murata
    Naoki Hasegawa
    Hideyuki Saya
    Yuko Kitagawa
    Koichi Fukunaga
    Masayuki Amagai
    Haruhiko Siomi
    Makoto Suematsu
    Kenjiro Kosaki
    Scientific Reports, 12
  • [27] A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
    Huang, Fangfang
    Li, Ying
    Leung, Elaine Lai-Han
    Liu, Xiaohua
    Liu, Kaifeng
    Wang, Qu
    Lan, Yongqi
    Li, Xiaoling
    Yu, Haibing
    Cui, Liao
    Luo, Hui
    Luo, Lianxiang
    PHARMACOLOGICAL RESEARCH, 2020, 158
  • [28] Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Mo-lecular Docking and Simulation Approach to Combat COVID-19
    Rehman, Md Tabish
    AlAjmi, Mohamed F.
    Hussain, Afzal
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (33) : 3577 - 3589
  • [29] Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19
    Fu, Jiewen
    Zhou, Baixu
    Zhang, Lianmei
    Balaji, Kyathegowdanadoddi Srinivasa
    Wei, Chunli
    Liu, Xiaoyan
    Chen, Hanchun
    Peng, Jiangzhou
    Fu, Junjiang
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (06) : 4383 - 4392
  • [30] Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19
    Jiewen Fu
    Baixu Zhou
    Lianmei Zhang
    Kyathegowdanadoddi Srinivasa Balaji
    Chunli Wei
    Xiaoyan Liu
    Hanchun Chen
    Jiangzhou Peng
    Junjiang Fu
    Molecular Biology Reports, 2020, 47 : 4383 - 4392
12345